On May 1, 2024, Smith & Nephew PLC reported Q1 2024 revenue of $1,386 million, a 2.9% increase from $1,356 million in Q1 2023, driven by growth in Orthopaedics and Sports Medicine despite a slight decline in Advanced Wound Management. The company maintains its full year revenue growth guidance at 5.0% to 6.0% and expects an 18.0% trading profit margin.